Princess Grace Hospital Centre

Over 1,000 Cardiac Patients Treated with Genesis Robotic System

Retrieved on: 
Thursday, April 13, 2023

ST. LOUIS, April 13, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that over 1,000 cardiac arrhythmia patients have been treated using the Genesis Robotic Magnetic Navigation (RMN) system.

Key Points: 
  • ST. LOUIS, April 13, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that over 1,000 cardiac arrhythmia patients have been treated using the Genesis Robotic Magnetic Navigation (RMN) system.
  • Since then, physicians at eight global hospitals have treated over 1,000 patients using Genesis RMN.
  • The Genesis RMN system introduces the benefits of robotic precision and safety to cardiac ablation, a common minimally invasive procedure to treat arrhythmias.
  • Physicians have used Genesis RMN to treat a broad spectrum of arrhythmia patients, including the underserved community of patients with complex cardiac disease that cannot be treated well or at all without Stereotaxis’ robotic technology.

First Patients Treated in Southern Europe with Stereotaxis Genesis Robotic Technology

Retrieved on: 
Monday, October 18, 2021

Electrophysiologists at Princess Grace Hospital have been among the pioneers of robotic cardiac ablation in Europe, becoming early adopters of Stereotaxis technology in 2006.

Key Points: 
  • Electrophysiologists at Princess Grace Hospital have been among the pioneers of robotic cardiac ablation in Europe, becoming early adopters of Stereotaxis technology in 2006.
  • Since then, more than 1,000 patients in Monaco have benefited from the precision and safety of Robotic Magnetic Navigation.
  • Dr. Gabriel Latcu, head of electrophysiology and deputy head of cardiology services at Princess Grace Hospital, has successfully treated the first patients with the new Genesis Robot, the first procedures performed with the technology in Southern Europe.
  • Robotic Magnetic Navigation has been a central technology in enabling us to successfully treat and research complex arrhythmias, says Dr. Latcu.